Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT and Competition

<< Previous

Bullboard Posts

Next >>

Comment by Antidoteon Nov 24, 2020 10:23pm

119 Views

Post# 31967234

RE:RE:TLT and Competition

Thanks for the clarification Enriquesuave. I see that Photofrin gave patients issues with stenosis due to collagen deposition and so it's not really used for NMIBC anymore. I can't find much recent info on Radachlorin. Do you know if it was discontinued? Or maybe they're just sticking with Russia for now? Thanks

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading